SPONSOR

Peking Union Medical College Hospital

Total Trials

Recruiting

Phases

Phase 2, Phase 1, Phase 2, Phase 3, Phase 1, Phase 2

Conditions studied: Diffuse Large B Cell Lymphoma CAR-T Radiotherapy Bridging Therapy Extranodal NK/T-cell Lymphoma Hepatocellular Carcinoma IgG4 Related Disease Coronary Artery Disease Coronary Artery Disease Progression Coronary Artery Stenosis

Peking Union Medical College Hospital is a clinical research sponsor with 23 registered studies on ClinicalTrials.gov, of which 23 are actively recruiting participants. Research covers conditions including Diffuse Large B Cell Lymphoma, CAR-T, Radiotherapy, Bridging Therapy.

The trial portfolio spans Phase 2, Phase 1, Phase 2, Phase 3 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.

Frequently Asked Questions — Peking Union Medical College Hospital

How many clinical trials has Peking Union Medical College Hospital sponsored?

ClinicalMetric currently tracks 23 clinical trials sponsored by Peking Union Medical College Hospital, of which 23 are actively recruiting participants. These trials cover conditions including Diffuse Large B Cell Lymphoma, CAR-T, Radiotherapy. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.

What therapeutic areas does Peking Union Medical College Hospital research focus on?

Peking Union Medical College Hospital clinical trials span Diffuse Large B Cell Lymphoma, CAR-T, Radiotherapy, Bridging Therapy, Extranodal NK/T-cell Lymphoma, and additional conditions. The research pipeline includes Phase 2, Phase 1, Phase 2, Phase 3 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.

How do I participate in a Peking Union Medical College Hospital clinical trial?

To participate in a Peking Union Medical College Hospital trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Peking Union Medical College Hospital trials with current recruitment status updated daily.

Peking Union Medical College Hospital

Frequently Asked Questions — Peking Union Medical College Hospital

Clinical Trials by Peking Union Medical College Hospital

A Study of Ultra-fraction Radiotherapy Bridging CART in R/R DLBCL

Sintilimab, Pegaspargase Plus GemOx for Untreated Extranodal NK/T-Cell Lymphoma

Combination of Cardonizumab Injection and TKI Second Line Therapy for Advanced Hepatocellular Cancer

A Randomized Controlled Study of the Efficacy and Safety of Lenalidomide in the Treatment of Active IgG4-related Disease

Clinical Features, Current Treatment and Clinical Outcomes in Patients With INR-CAD: a Cohort Study

Head-to-head Comparison of Diagnosis Value of Pulmonary Fibrosis on 68Ga-FAPI-04 and 18F-FDG PET-CT

Application of [68Ga]Ga-NI-FAPI-04 PET/CT Imaging in Fibroblast Activation Protein Related Diseases

Risk Factor Assessment for Acute Pulmonary Hypertension Crisis

Phase II Study of Trastuzumab Rezetecan Combined With Adebrelimab and Lenvatinib in Advanced HER2-Positive/Low-Expression Biliary Tract Cancer

The Role of AAT After Abdominal Surgery Based on RWS

Spectral CT in Radiotherapy for Cervical Cancer

Wearable Accelerometers for Predicting Perioperative Risk in Elderly Patients

Geno-radiomics Based Model for Evaluation of Immunotherapy and Targeted Therapy for Advanced Soft Tissue Sarcoma

An Exploratory Study of QL1706 Plus Chemotherapy in Perioperative NSCLC

Treatment of Irinotecan Hydrochloride Liposome Injection II in China: a Real World Study of Pancreatic Cancer Patients

Spatial Multi-omics and Intelligent Early Warning of Pancreatic Cancer Cachexia

Effect of a Localized ICU AI Teaching Agent on Rotating ICU Residents

POASAC Study (Preoperative Anemia Severity and Classification Study)

Observational Study of Pediatric Rheumatic and Immunologic Diseases in China: The CAPRID Registry

TPO-RA Treatment on Immune Tolerance Induction of ITP Patients With Sustained Platelet Recovery After Treatment Termination

Online Adaptive Radiotherapy for Cervical Cancer

The Value of Molecular Residual Disease Monitoring Based on ctDNA in Resected Pancreatic Cancer

Efficacy and Safety of Comprehensive Treatment in Patients With IR-CAD: a Self-controlled Cohort Study